1. Home
  2. PLSE vs BLND Comparison

PLSE vs BLND Comparison

Compare PLSE & BLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • BLND
  • Stock Information
  • Founded
  • PLSE 2014
  • BLND 2012
  • Country
  • PLSE United States
  • BLND United States
  • Employees
  • PLSE N/A
  • BLND N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • BLND EDP Services
  • Sector
  • PLSE Health Care
  • BLND Technology
  • Exchange
  • PLSE Nasdaq
  • BLND Nasdaq
  • Market Cap
  • PLSE 1.1B
  • BLND 925.5M
  • IPO Year
  • PLSE 2016
  • BLND 2021
  • Fundamental
  • Price
  • PLSE $15.51
  • BLND $3.61
  • Analyst Decision
  • PLSE Buy
  • BLND Buy
  • Analyst Count
  • PLSE 1
  • BLND 6
  • Target Price
  • PLSE $22.00
  • BLND $4.88
  • AVG Volume (30 Days)
  • PLSE 165.2K
  • BLND 3.6M
  • Earning Date
  • PLSE 08-12-2025
  • BLND 08-07-2025
  • Dividend Yield
  • PLSE N/A
  • BLND N/A
  • EPS Growth
  • PLSE N/A
  • BLND N/A
  • EPS
  • PLSE N/A
  • BLND N/A
  • Revenue
  • PLSE N/A
  • BLND $167,776,000.00
  • Revenue This Year
  • PLSE N/A
  • BLND N/A
  • Revenue Next Year
  • PLSE $700.00
  • BLND $29.08
  • P/E Ratio
  • PLSE N/A
  • BLND N/A
  • Revenue Growth
  • PLSE N/A
  • BLND 29.83
  • 52 Week Low
  • PLSE $13.77
  • BLND $2.64
  • 52 Week High
  • PLSE $25.00
  • BLND $5.53
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 49.97
  • BLND 57.31
  • Support Level
  • PLSE $15.22
  • BLND $3.41
  • Resistance Level
  • PLSE $17.34
  • BLND $3.65
  • Average True Range (ATR)
  • PLSE 0.88
  • BLND 0.19
  • MACD
  • PLSE 0.03
  • BLND 0.07
  • Stochastic Oscillator
  • PLSE 39.97
  • BLND 82.41

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

About BLND Blend Labs Inc.

Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.

Share on Social Networks: